Ventiv to Deliver Glaxo Program

Share this article:
Ventiv Health Communications, New York, the former Snyder Healthcare Communications that was recently spun off into an independent public company, said this week it will create a migraine campaign for Glaxo Wellcome.


The integrated marketing program, called e.Scape Migraine, will target physicians and focus on migraine diagnosis and treatment education.


Separately, Ventiv and Snyder share prices both have performed poorly, hitting 52-week lows consistently since the September 28 spin-off occurred. Snyder Communications did not return calls seeking comment. Snyder Communications' stock price was $12.50 as of Oct. 15; Ventiv's was $7.88 the same day.
Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Agency

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in Agency

Are You Really Ready for Customer Experience?

Are You Really Ready for Customer Experience?

Marketers can talk a good game about customer centricity, but actions speak louder than words.

Essentials in Content Marketing: Think like a best-selling author

Essentials in Content Marketing: Think like a best-selling ...

Imagine if all the electronic content thrown your way daily was actually printed on paper. To stand out from those piles of worthless pixels, you must offer your audiences intriguing ...

The Mobile-Email Marriage

The Mobile-Email Marriage

Marketers who considered leaving email at the altar are finding renewed passion for the channel as an ever-increasing number of customers triage, read, and click-through email on their smartphones.